Literature DB >> 19431031

Using quality improvement methodology to improve neuropathic pain screening and assessment in patients with cancer.

Ellen M Lavoie Smith1, Marie A Bakitas, Peter Homel, Camilo Fadul, Louise Meyer, Karen Skalla, Marilyn Bookbinder.   

Abstract

BACKGROUND: Quality improvement methodology was used to improve neuropathic pain (NP) screening at a comprehensive cancer center.
METHODS: Nurses participated in educational sessions about screening and assessment. Clinical systems to facilitate documentation of NP severity scores were developed.
RESULTS: Pretest and posttest score results demonstrated nurse acquisition of new knowledge. A 90% NP screening adherence rate was achieved (N = 3831). Patients with no reported general pain (n = 291) were found to have moderate to severe NP.
CONCLUSIONS: Keys to success are (1) health care professional education and periodic reinforcement of learning and (2) system infrastructure changes.

Entities:  

Mesh:

Year:  2009        PMID: 19431031     DOI: 10.1080/08858190902854715

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   1.771


  13 in total

1.  Quality improvement of painful peripheral neuropathy.

Authors:  Ellen Lavoie Smith; Marie Bakitas Whedon; Marilyn Bookbinder
Journal:  Semin Oncol Nurs       Date:  2002-02       Impact factor: 2.315

Review 2.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

Authors:  Robert H Dworkin; Miroslav Backonja; Michael C Rowbotham; Robert R Allen; Charles R Argoff; Gary J Bennett; M Catherine Bushnell; John T Farrar; Bradley S Galer; Jennifer A Haythornthwaite; David J Hewitt; John D Loeser; Mitchell B Max; Mario Saltarelli; Kenneth E Schmader; Christoph Stein; David Thompson; Dennis C Turk; Mark S Wallace; Linda R Watkins; Sharon M Weinstein
Journal:  Arch Neurol       Date:  2003-11

3.  Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale.

Authors:  B S Galer; M P Jensen
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

4.  The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial.

Authors:  Mark P Jensen; Michael Friedman; Daniel Bonzo; Patricia Richards
Journal:  Clin J Pain       Date:  2006-01       Impact factor: 3.442

5.  Peripheral neuropathic pain--a multidimensional burden for patients.

Authors:  K Meyer-Rosberg; A Kvarnström; E Kinnman; T Gordh; L O Nordfors; A Kristofferson
Journal:  Eur J Pain       Date:  2001       Impact factor: 3.931

6.  Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life.

Authors:  B S Galer; A Gianas; M P Jensen
Journal:  Diabetes Res Clin Pract       Date:  2000-02       Impact factor: 5.602

7.  Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.

Authors:  Mark P Jensen; Robert H Dworkin; Arnold R Gammaitoni; David O Olaleye; Napoleon Oleka; Bradley S Galer
Journal:  J Pain       Date:  2005-02       Impact factor: 5.820

Review 8.  Cancer pain: how to measure the fifth vital sign.

Authors:  Mellar P Davis; Declan Walsh
Journal:  Cleve Clin J Med       Date:  2004-08       Impact factor: 2.321

9.  Cancer pain management and the JCAHO's pain standards: an institutional challenge.

Authors:  Marlene Zichi Cohen; Mary K Easley; Coni Ellis; Beverly Hughes; Kristin Ownby; Beverly Green Rashad; Mari Rude; Ellen Taft; Joycelyn Bailey Westbrooks
Journal:  J Pain Symptom Manage       Date:  2003-06       Impact factor: 3.612

10.  Background noise: the experience of chemotherapy-induced peripheral neuropathy.

Authors:  Marie A Bakitas
Journal:  Nurs Res       Date:  2007 Sep-Oct       Impact factor: 2.381

View more
  6 in total

1.  Examining the Impact of a Web-Based Intervention to Promote Patient Activation in Chemotherapy-Induced Peripheral Neuropathy Assessment and Management.

Authors:  Robert Knoerl; Deborah Lee; James Yang; Celia Bridges; Grace Kanzawa-Lee; G Lita Smith; Ellen M Lavoie Smith
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

Review 2.  Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.

Authors:  Ellen M Lavoie Smith; Celia M Bridges; Grace Kanzawa; Robert Knoerl; James P Kelly; Anna Berezovsky; Charis Woo
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 3.  Nursing's role in cancer pain management.

Authors:  April Hazard Vallerand; Susan Musto; Rosemary C Polomano
Journal:  Curr Pain Headache Rep       Date:  2011-08

4.  Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.

Authors:  Robert Knoerl; Evan Gray; Carrie Stricker; Sandra A Mitchell; Kelsey Kippe; Gloria Smith; William N Dudley; Ellen M Lavoie Smith
Journal:  Support Care Cancer       Date:  2017-06-02       Impact factor: 3.603

5.  Chemotherapy-induced peripheral neuropathy. Part II. Prevention.

Authors:  Krzysztof Brzeziński
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

Review 6.  Implementation of improvement strategies in palliative care: an integrative review.

Authors:  Jasper van Riet Paap; Myrra Vernooij-Dassen; Ragni Sommerbakk; Wendy Moyle; Marianne J Hjermstad; Wojciech Leppert; Kris Vissers; Yvonne Engels
Journal:  Implement Sci       Date:  2015-07-26       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.